Matinas Increases Authorized Capital Stock and Announces Reverse Stock Split
Matinas BioPharma increased authorized capital stock to 510 million shares and will conduct a 1-for-15 reverse stock split effective Sept. 28, 2026.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed